GlassScriptPhysician profile
Robert Y Knowlton
NPI 1952690984
$2,516.74
in general payments reported to CMS, 2019-2025
33 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $108 · 2021: $14.13 · 2022: $921 · 2023: $595 · 2024: $372 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $487.74 | 2019-2024 | |
| Astellas Pharma US INC | $207.60 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $199.90 | 2022-2023 | Ova1 |
| Daiichi Sankyo INC. | $195.12 | 2022-2025 | Injectafer |
| Pfizer INC. | $144.40 | 2022-2024 | |
| Exeltis, USA INC. | $142.06 | 2022-2025 | Slynd |
| Sumitomo Pharma America, INC. | $108.75 | 2023-2025 | Myfembree, Gemtesa |
| Exact Sciences Corporation | $108.35 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $83.92 | 2022-2025 | |
| Novo Nordisk INC | $83.59 | 2022-2024 | Wegovy |
| Sage Therapeutics, LLC | $81.07 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $60.75 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.70 | 2022 | |
| Mayne Pharma Commercial LLC | $48.29 | 2022-2024 | |
| Therapeuticsmd, INC. | $47.56 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $45.30 | 2022 | |
| Scynexis, INC. | $42.84 | 2022 | |
| Myovant Sciences INC. | $40.36 | 2022 | |
| Optumhealth Care Solutions, LLC | $39.67 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Shield Therapeutics INC | $37.66 | 2022-2023 | Accrufer |
| Pacira Pharmaceuticals Incorporated | $35.50 | 2024-2025 | Exparel |
| Avion Pharmaceuticals | $34.07 | 2022 | |
| Dexcom, INC. | $27.83 | 2023 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $21.39 | 2025 | Qelbree |
| Mylan Pharmaceuticals INC. | $21.23 | 2022 | |
| Meditrina | $20.70 | 2023 | |
| Coopersurgical, INC. | $15.15 | 2023 | Paragard T 380a |
| Takeda Pharmaceuticals U.S.A., INC. | $14.61 | 2022 | |
| Merck Sharp & Dohme LLC | $14.19 | 2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $14.13 | 2021 | |
| Boston Scientific Corporation | $13.49 | 2022 | |
| Channel Medsystems, INC. | $10.92 | 2025 | |
| Organon LLC | $9.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Knowlton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.